|
Volumn 26, Issue 2, 2008, Pages 143-151
|
Selective cyclooxygenase-2 inhibitor prevents reduction of trabecular bone mass in collagen-induced arthritic mice in association with suppression of RANKL/OPG ratio and IL-6 mRNA expression in synovial tissues but not in bone marrow cells
|
Author keywords
Arthritis; Bone marrow; Cyclooxygenase; Osteoclast; RANKL
|
Indexed keywords
CELECOXIB;
COLLAGEN;
CYCLOOXYGENASE 2 INHIBITOR;
INDOMETACIN;
INTERLEUKIN 6;
MESSENGER RNA;
OSTEOCALCIN;
OSTEOCLAST DIFFERENTIATION FACTOR;
OSTEOPROTEGERIN;
SC 58560;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
BONE ATROPHY;
BONE MARROW CULTURE;
BONE MASS;
CONTROLLED STUDY;
GENE EXPRESSION;
HISTOPHOTOMETRY;
MALE;
MOUSE;
NONHUMAN;
OSSIFICATION;
OSTEOCLAST;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
QUANTITATIVE ANALYSIS;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RHEUMATOID ARTHRITIS;
SYNOVIUM;
THERAPY EFFECT;
TIBIA;
TRABECULAR BONE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
AMINO ACIDS;
ANIMALS;
ARTHRITIS, EXPERIMENTAL;
BIOLOGICAL MARKERS;
BODY WEIGHT;
BONE AND BONES;
BONE MARROW CELLS;
CELLS, CULTURED;
CYCLOOXYGENASE 2 INHIBITORS;
GENE EXPRESSION REGULATION;
INTERLEUKIN-6;
MALE;
MICE;
ORGAN SIZE;
OSTEOCALCIN;
OSTEOPROTEGERIN;
RANK LIGAND;
RNA, MESSENGER;
SYNOVIAL MEMBRANE;
TIBIA;
|
EID: 39849096717
PISSN: 09148779
EISSN: None
Source Type: Journal
DOI: 10.1007/s00774-007-0808-2 Document Type: Article |
Times cited : (21)
|
References (36)
|